RU2176638C2 - Замещенные инданилидинацетилгуанидины, способ их получения, применение в качестве лекарственных или диагностических средств и лекарственные средства, содержащие эти соединения - Google Patents

Замещенные инданилидинацетилгуанидины, способ их получения, применение в качестве лекарственных или диагностических средств и лекарственные средства, содержащие эти соединения Download PDF

Info

Publication number
RU2176638C2
RU2176638C2 RU97113146/04A RU97113146A RU2176638C2 RU 2176638 C2 RU2176638 C2 RU 2176638C2 RU 97113146/04 A RU97113146/04 A RU 97113146/04A RU 97113146 A RU97113146 A RU 97113146A RU 2176638 C2 RU2176638 C2 RU 2176638C2
Authority
RU
Russia
Prior art keywords
formula
compound
manufacture
medicament
treatment
Prior art date
Application number
RU97113146/04A
Other languages
English (en)
Russian (ru)
Other versions
RU97113146A (ru
Inventor
Нироги Венката Сать РАМАКРИШНА (IN)
Нироги Венката Сатья РАМАКРИШНА
Кумар Яин Арун (IN)
Кумар Яин Арун
Банси ЛАЛ (IN)
Банси ЛАЛ
Рао Венката Сать Веерабхадра ВАДЛАМУДИ (IN)
Рао Венката Сатья Веерабхадра ВАДЛАМУДИ
Анил Вазантрао ГХАТЕ (IN)
Анил Вазантрао ГХАТЕ
Равиндра Даттатрайа ГУПТЕ (IN)
Равиндра Даттатрайа ГУПТЕ
Андреас ВАЙХЕРТ (DE)
Андреас Вайхерт
Ян-Роберт ШВАРК (DE)
Ян-Роберт Шварк
Original Assignee
Хехст АГ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хехст АГ filed Critical Хехст АГ
Publication of RU97113146A publication Critical patent/RU97113146A/ru
Application granted granted Critical
Publication of RU2176638C2 publication Critical patent/RU2176638C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/38—Amides of thiocarboxylic acids
    • C07C327/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C327/54—Y being a hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
RU97113146/04A 1996-07-30 1997-07-29 Замещенные инданилидинацетилгуанидины, способ их получения, применение в качестве лекарственных или диагностических средств и лекарственные средства, содержащие эти соединения RU2176638C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96112275A EP0837055A1 (en) 1996-07-30 1996-07-30 Substituted Indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them
EP96112275.1 1996-07-30

Publications (2)

Publication Number Publication Date
RU97113146A RU97113146A (ru) 1999-05-27
RU2176638C2 true RU2176638C2 (ru) 2001-12-10

Family

ID=8223055

Family Applications (1)

Application Number Title Priority Date Filing Date
RU97113146/04A RU2176638C2 (ru) 1996-07-30 1997-07-29 Замещенные инданилидинацетилгуанидины, способ их получения, применение в качестве лекарственных или диагностических средств и лекарственные средства, содержащие эти соединения

Country Status (29)

Country Link
US (1) US5900436A (enExample)
EP (2) EP0837055A1 (enExample)
JP (1) JP4039589B2 (enExample)
KR (1) KR980009236A (enExample)
CN (1) CN1064351C (enExample)
AR (1) AR008095A1 (enExample)
AT (1) ATE207888T1 (enExample)
AU (1) AU715187B2 (enExample)
BR (1) BR9704131A (enExample)
CA (1) CA2211982C (enExample)
CZ (1) CZ241197A3 (enExample)
DE (1) DE69707777T2 (enExample)
DK (1) DK0822182T3 (enExample)
ES (1) ES2164283T3 (enExample)
HR (1) HRP970424B1 (enExample)
HU (1) HUP9701316A3 (enExample)
ID (1) ID17565A (enExample)
IL (1) IL121407A0 (enExample)
MX (1) MX9705737A (enExample)
NO (1) NO308213B1 (enExample)
NZ (1) NZ328440A (enExample)
PL (1) PL321392A1 (enExample)
PT (1) PT822182E (enExample)
RU (1) RU2176638C2 (enExample)
SI (1) SI0822182T1 (enExample)
SK (1) SK282128B6 (enExample)
TR (1) TR199700704A2 (enExample)
TW (1) TW445251B (enExample)
ZA (1) ZA976735B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018129556A1 (en) 2017-01-09 2018-07-12 Ardelyx, Inc. Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
CN103819403B (zh) 2008-12-31 2017-01-04 阿德利克斯公司 用于治疗与体液潴留或盐超负荷有关的病症和胃肠道病症的化合物和方法
GB0916163D0 (en) * 2009-09-15 2009-10-28 Shire Llc Prodrugs of guanfacine
CN105392483B (zh) 2013-04-12 2019-03-15 阿德利克斯公司 用于抑制磷酸盐转运的nhe3结合化合物和方法
EA201991676A1 (ru) 2017-01-09 2020-01-30 Арделикс, Инк. Ингибиторы nhe-опосредованного антипорта
KR20240090875A (ko) 2017-01-09 2024-06-21 알데릭스, 인코포레이티드 위장관 장애를 치료하는 데 유용한 화합물
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ
CN116492469A (zh) * 2023-05-22 2023-07-28 遵义医科大学附属医院 一种通道阻滞剂在制备治疗和/或预防肝纤维疾病药物中的应用
CN119118881B (zh) * 2024-07-25 2026-01-02 中国农业大学 含胍基的5-氯茚满化合物及其制备方法与应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0738712A1 (en) * 1995-04-18 1996-10-23 Hoechst Aktiengesellschaft Anti-arrhythmic and cardioprotective substituted indenoylguanidines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DE4421536A1 (de) * 1994-06-20 1995-12-21 Hoechst Ag Perfluoralkylgruppen tragende phenylsubstituierte Alkenylcarbonsäure-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0738712A1 (en) * 1995-04-18 1996-10-23 Hoechst Aktiengesellschaft Anti-arrhythmic and cardioprotective substituted indenoylguanidines

Also Published As

Publication number Publication date
KR980009236A (ko) 1998-04-30
ZA976735B (en) 1998-01-30
TW445251B (en) 2001-07-11
NZ328440A (en) 1997-11-24
JPH1129545A (ja) 1999-02-02
EP0822182B1 (en) 2001-10-31
NO973486D0 (no) 1997-07-29
BR9704131A (pt) 1998-12-29
NO308213B1 (no) 2000-08-14
JP4039589B2 (ja) 2008-01-30
CA2211982C (en) 2007-09-18
ES2164283T3 (es) 2002-02-16
PL321392A1 (en) 1998-02-02
HUP9701316A3 (en) 1998-07-28
PT822182E (pt) 2002-03-28
CN1064351C (zh) 2001-04-11
SK282128B6 (sk) 2001-11-06
AR008095A1 (es) 1999-12-09
ID17565A (id) 1998-01-08
SK103497A3 (en) 1998-02-04
HRP970424B1 (en) 2002-06-30
EP0837055A1 (en) 1998-04-22
AU3155497A (en) 1998-02-05
HRP970424A2 (en) 1998-06-30
HUP9701316A2 (hu) 1998-03-02
EP0822182A1 (en) 1998-02-04
DE69707777T2 (de) 2003-01-16
HU9701316D0 (en) 1997-09-29
CN1172104A (zh) 1998-02-04
AU715187B2 (en) 2000-01-20
CZ241197A3 (cs) 1998-02-18
IL121407A0 (en) 1998-01-04
ATE207888T1 (de) 2001-11-15
TR199700704A2 (xx) 1998-02-21
NO973486L (no) 1998-02-02
US5900436A (en) 1999-05-04
MX9705737A (es) 1998-02-28
CA2211982A1 (en) 1998-01-30
DK0822182T3 (da) 2002-02-25
DE69707777D1 (de) 2001-12-06
SI0822182T1 (en) 2002-04-30

Similar Documents

Publication Publication Date Title
RU2193026C2 (ru) Фенилзамещенные гуанидиды алкенилкарбоновой кислоты и лекарственное средство на их основе
KR100360127B1 (ko) 치환된1-옥소-1,2-디하이드로이소퀴놀리노일구아니딘,1,1-디옥소-2h-1,2-벤조티아지노일구아니딘및이들을함유하는약제
KR100368513B1 (ko) 퍼플루오로알킬그룹을갖는페닐-치환된알케닐카보구아니디드,이의제조방법및이를함유하는약제학적조성물
JP3718240B2 (ja) 置換ベンゾイルグアニジン、その製造方法およびそれを含有する医薬
US6087304A (en) Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
SK282018B6 (sk) Substituované guanididy kyseliny škoricovej, spôsob ich výroby, ich použitie ako liečiva alebo diagnostika, ako aj liečivo, ktoré ich obsahuje
RU2160727C2 (ru) Бензоилгуанидины, способ их получения, промежуточное соединение для их получения, способ ингибирования и лекарственное средство
JP4039589B2 (ja) 置換インダニリジンアセチルグアニジン類、それらの製造方法、医薬または診断剤としてのそれらの使用およびそれらを含有する医薬
JPH08291131A (ja) 抗不整脈および心臓保護性の置換されたインデノイルグアニジン
RU2182901C2 (ru) Замещенные 1-нафтоилгуанидины и лекарственное средство на их основе
JPH1067731A (ja) オルト−置換されたベンゾイルグアニジン、その製法、医薬または診断剤としてのその使用およびそれを含有する医薬
JP3977897B2 (ja) オルト−置換されたベンゾイルグアニジン、それらの製法、医薬または診断剤としてのそれらの使用およびそれらを含有する医薬
JP4160650B2 (ja) オルト置換されたベンゾイルグアニジン、その製造法、医薬または診断剤としてのその使用およびそれを含む医薬
JPH1081662A (ja) ビス−オルト−置換されたベンゾイルグアニジン、その製法、医薬または診断剤としてのその使用およびそれを含有する医薬
JPH107644A (ja) オルト−置換されたベンゾイルグアニジン、それらの製造方法、医薬または診断薬としてのそれらの使用およびそれらを含有する医薬
MXPA97003871A (en) Benzoilguanidinas bis-orto-replaced, procedure for its preparation, its employment as a diagnostic medicine or agent, as well as a medication that conti
MXPA97003921A (en) 1-naftoilguanidinas substitute, procedure for its preparation, its employment as a medicine or diagnostic agent, as well as a medication that the
MXPA97003922A (en) 2-naftoilguanidinas substituted, procedure for preparation, its employment as a diagnostic occasive drug, as well as a medicinal product chelas conti

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20040730